{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:33:52Z","timestamp":1786991632792,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jchromb.2024.124423","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T01:56:27Z","timestamp":1733968587000},"page":"124423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development and validation of a quantification method for direct oral anticoagulants from capillary blood using volumetric absorptive microsampling and online SPE-LC-MS"],"prefix":"10.1016","volume":"1251","author":[{"given":"Patrick","family":"Opitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Waltering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5790-6423","authenticated-orcid":false,"given":"Georg","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2024.124423_b0005","unstructured":"S. B\u00f6hr, Therapeutisches Drug Monitoring der direkten oralen Antikoagulanzien. Dissertation, Regensburg, 2018."},{"key":"10.1016\/j.jchromb.2024.124423_b0010","first-page":"64","article-title":"Neue orale Antikoagulanzien Apixaban","volume":"34","author":"Lipp","year":"2013","journal-title":"Dabigatranetexilat Und Rivaroxaban, Krankenhauspharmazie"},{"key":"10.1016\/j.jchromb.2024.124423_b0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bjh.13810","article-title":"Laboratory measurement of the direct oral anticoagulants","volume":"172","author":"Dale","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jchromb.2024.124423_b0020","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/chromsci\/bmw122","article-title":"Characterization of the Fluorescent Spectra and Intensity of Dabigatran and Dabigatran Etexilate","volume":"54","author":"Schwertner","year":"2016","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2024.124423_b0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/FTD.0000000000000355","article-title":"Development of an UHPLC-UV-Method for Quantification of Direct Oral Anticoagulants: Apixaban, Rivaroxaban, Dabigatran, and its Prodrug Dabigatran Etexilate in Human Serum \/\/ Development of an UHPLC-UV-Method for Quantification of Direct Oral Anticoagulants","volume":"39","author":"Boehr","year":"2017","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jchromb.2024.124423_b0030","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/jth.12702","article-title":"Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS\/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants","volume":"12","author":"Schmitz","year":"2014","journal-title":"Journal of Thrombosis and Haemostasis: JTH"},{"key":"10.1016\/j.jchromb.2024.124423_b0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4155\/bio.15.261","article-title":"Validation of an LC-MS\/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma","volume":"8","author":"Baldelli","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2024.124423_b0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/FTD.0000000000000509","article-title":"Quantification of Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in Human Serum by UHPLC-MS\/MS-Method Development, Validation, and Application","volume":"40","author":"Lindahl","year":"2018","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jchromb.2024.124423_b0045","doi-asserted-by":"crossref","first-page":"e4213","DOI":"10.1002\/bmc.4213","article-title":"A quantitative LC\/MSMS method for determination of edoxaban, a Xa inhibitor and its pharmacokinetic application in patients after total knee arthroplasty","volume":"32","author":"Hanada","year":"2018","journal-title":"Biomedical Chromatography: BMC"},{"key":"10.1016\/j.jchromb.2024.124423_b0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.aca.2018.09.004","article-title":"Tutorial","volume":"1046","author":"Protti","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2024.124423_b0055","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.4155\/bio-2020-0136","article-title":"Validation and clinical application of a volumetric absorptive microsampling method for 14 psychiatric drugs","volume":"12","author":"Stern","year":"2020","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2024.124423_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2021.106551","article-title":"Evaluation of inhibitors of the arachidonic acid cascade with intact platelets using an on-line dilution and on-line solid phase extraction HPLC-MS method","volume":"155","author":"Fabian","year":"2021","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jchromb.2024.124423_b0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpba.2018.04.001","article-title":"Extractability-mediated stability bias and hematocrit impact","volume":"156","author":"Xie","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124423_b0070","unstructured":"European Medicines Agency, Guideline on bioanalytical method validation, 2015, https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf, accessed 31 January 2020 at 11:01 am."},{"key":"10.1016\/j.jchromb.2024.124423_b0075","unstructured":"European Medicines Agency, ICH guideline M10 Step2b on bioanalytical method validation, 2019, https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-ich-guideline-m10-bioanalytical-method-validation-step-2b_en.pdf, accessed 31 January 2020 at 10:57 am."},{"key":"10.1016\/j.jchromb.2024.124423_b0080","article-title":"Department of Health and Human Services - Food and Drug Administration (FDA)","author":"U.s.","year":"2018","journal-title":"Bioanalytical Method Validation - Guidance for Industry"},{"key":"10.1016\/j.jchromb.2024.124423_b0085","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2024.124423_b0090","unstructured":"MVZ Dr. Eberhard & Partner Dortmund, Medizinisches Versorgungszentrum Dortmund_Untersuchungen_Untersuchungsprogramm, 2023, https:\/\/www.medizin-zentrum-dortmund.de\/de\/untersuchungsprogramm_print.php?abteilung=43&kapitel=3000, accessed 8 January 2024 at 9:54 am."},{"key":"10.1016\/j.jchromb.2024.124423_b0095","unstructured":"Ratiopharm GmbH, Phenpro.-ratiopharm\u00ae 3 mg Tabletten, 2020, https:\/\/www.fachinfo.de\/api\/fachinfo\/pdf\/005121, accessed 8 January 2024 at 9:44 am."},{"key":"10.1016\/j.jchromb.2024.124423_b0100","unstructured":"D.R. Spahn, A. Borgeat, C. Kern, Chassot, P.G., Steffel, J., W. Korte, Edoxaban_Guidline f\u00fcr An\u00e4sthesisten (2015) 1\u201323."},{"key":"10.1016\/j.jchromb.2024.124423_b0105","unstructured":"F.v. Bruchhausen, M. Albinus, R. Braun, H. Hager (Eds.), Stoffe P-Z: Mit 1498 Formeln, 5th ed., Springer, Berlin, 1994."},{"key":"10.1016\/j.jchromb.2024.124423_b0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-4347(00)80511-3","article-title":"Determination of the anticoagulant phenprocoumon in human plasma and urine by high-performance liquid chromatography","volume":"231","author":"DeVries","year":"1982","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2024.124423_b0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/aas.12319","article-title":"New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications","volume":"58","author":"Fenger-Eriksen","year":"2014","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.jchromb.2024.124423_b0120","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2024.124423_b0125","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.clinbiochem.2016.05.004","article-title":"Dried blood spots analysis with mass spectrometry","volume":"49","author":"Antunes","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jchromb.2024.124423_b0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2478\/acm-2023-0004","article-title":"Volumetric Absorptive Microsampling Technique in the LC-MS Determination of Direct Oral Anticoagulants","volume":"23","author":"Nela","year":"2023","journal-title":"Acta Medica Martiniana"},{"key":"10.1016\/j.jchromb.2024.124423_b0135","year":"2021","journal-title":"Phenprocoumon"},{"key":"10.1016\/j.jchromb.2024.124423_b0140","series-title":"Klinische Analytik mit HPLC: Ein Ratgeber f\u00fcr die Praxis","author":"Mascher","year":"2010"},{"key":"10.1016\/j.jchromb.2024.124423_b0145","unstructured":"LGC Limited, safety data sheet: apixaban, 2021, https:\/\/assets.lgcstandards.com\/sys-master%2Fpdfs%2Fhf8%2Fhc0%2F10429070344222%2FSDS_TRC-A726700-10MG_ST-WB-MSDS-3826947-1-1-1.PDF, accessed 14 July 2023."},{"key":"10.1016\/j.jchromb.2024.124423_b0150","unstructured":"Sigma-Aldrich Chemie GmbH, safety data sheet: dabigatran, 2022, https:\/\/www.sigmaaldrich.com\/DE\/de\/sds\/sigma\/sml2370, accessed 14 July 2023."},{"key":"10.1016\/j.jchromb.2024.124423_b0155","unstructured":"Sigma-Aldrich Chemie GmbH, safty data sheet: rivaroxaban, 2023, https:\/\/www.sigmaaldrich.com\/DE\/de\/sds\/sigma\/sml2844, accessed 14 July 2023."},{"key":"10.1016\/j.jchromb.2024.124423_b0160","unstructured":"Sigma-Aldrich Chemie GmbH, safety data sheet: phenprocoumon, 2023, https:\/\/www.sigmaaldrich.com\/DE\/de\/sds\/sigma\/sml2370, accessed 14 July 2023."},{"key":"10.1016\/j.jchromb.2024.124423_b0165","unstructured":"European Medicines Agency, Lixiana: EPAR - Product Information: Anhang 1 - Zusammenfassung der Merkmale des Arzneimittels, 2023, https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/lixiana-epar-product-information_de.pdf, accessed 8 January 2024 at 9:42 am."},{"key":"10.1016\/j.jchromb.2024.124423_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113597","article-title":"Quantitative microsampling for bioanalytical applications related to the SARS-CoV-2 pandemic: Usefulness, benefits and pitfalls","volume":"191","author":"Protti","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124423_b0175","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jchromb.2006.12.050","article-title":"A rapid method for the quantification of the enantiomers of Warfarin, Phenprocoumon and Acenocoumarol by two-dimensional-enantioselective liquid chromatography\/electrospray tandem mass spectrometry, Journal of chromatography","volume":"850","author":"Vecchione","year":"2007","journal-title":"B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"10.1016\/j.jchromb.2024.124423_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.679431","article-title":"Measurement of Dabigatran Concentration Using Finger Prick Dried Blood Spot Sample Collection","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jchromb.2024.124423_b0185","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4155\/bio-2019-0180","article-title":"Validation and clinical application of dried blood spot assay for quantitative assessment of edoxaban in healthy adults","volume":"12","author":"He","year":"2020","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2024.124423_b0190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jchromb.2015.02.023","article-title":"\u201cCenter punch\u201d and \u201cwhole spot\u201d bioanalysis of apixaban in human dried blood spot samples by UHPLC-MS\/MS, Journal of chromatography","volume":"988","author":"Zheng","year":"2015","journal-title":"B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"10.1016\/j.jchromb.2024.124423_b0195","doi-asserted-by":"crossref","first-page":"9395","DOI":"10.1021\/acs.analchem.8b02046","article-title":"Dried-Blood-Spot Technique to Monitor Direct Oral Anticoagulants","volume":"90","author":"Foerster","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2024.124423_b0200","unstructured":"A. Gujar, P. Silcock, A. Semyonov, Comparison of Single and Triple Quadrupole GC-MS Instruments for Full Scan Analysis of Semivolatile Organic Compounds. Technical Note 10431, 2016."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322400432X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322400432X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T09:57:08Z","timestamp":1736416628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157002322400432X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"alternative-id":["S157002322400432X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124423","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a quantification method for direct oral anticoagulants from capillary blood using volumetric absorptive microsampling and online SPE-LC-MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"124423"}}